A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. 1985

D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper

This paper describes a suppressor T cell factor which protects mice against intraabdominal abscesses caused by Bacteroides fragilis. This soluble cell-free factor (ITF) is derived from splenic T cells from mice immunized with capsular polysaccharide (CP) of B. fragilis. Mice receiving ITF are protected from developing abscesses caused by B. fragilis to the same degree as animals receiving intact immune splenic T cells. The factor appears to be small in molecular size as protective activity is dialyzable through a 12,000-mol wt exclusion dialysis membrane and is present in fractions intermediate between the bed and void volumes of a P2 Biogel column. The protective effect of ITF is antigen-specific to B. fragilis alone. Mice given a complex inoculum of B. fragilis, enterococcus, and another anaerobe develop abscesses even after receiving column-purified ITF. The activity of ITF also is eliminated after adsorption with B. fragilis CP coupled to sheep erythrocytes but not with an unrelated CP coupled to sheep erythrocytes. ITF, therefore, appears to have a binding site for B. fragilis CP. ITF is heat-labile and loses efficacy after protease digestion, suggesting that the active material is a protein. These studies define a suppressor cell factor with activity in a model system resembling human disease and offer promise for increased understanding of the diversity of cell-mediated immune systems.

UI MeSH Term Description Entries
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D000005 Abdomen That portion of the body that lies between the THORAX and the PELVIS. Abdomens
D000038 Abscess Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection. Abscesses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
January 1990, Reviews of infectious diseases,
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
February 1982, New York state journal of medicine,
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
January 1985, Methods in enzymology,
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
January 2018, Journal of autoimmunity,
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
January 1977, Nature,
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
February 2007, Journal of immunology (Baltimore, Md. : 1950),
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
December 2001, The Journal of experimental medicine,
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
August 1982, Surgery,
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
May 2011, Journal of neuroimmunology,
D F Zaleznik, and R W Finberg, and M E Shapiro, and A B Onderdonk, and D L Kasper
January 1983, Acta dermato-venereologica,
Copied contents to your clipboard!